PRO Yellow

vascular laser diode pro yellow solid state View More Photos

Product Info

PRO yellow dermatological laser yellow tabletop vascular
PRO Yellow is the world’s first tabletop vascular laser, outputting at 577 nm – an ideal wavelength for absorption by oxyhaemoglobin. The 577 nm wavelength delivers 39% more blood absorption than 532 nm, and 75% more than 1064 nm, but with significantly lower melanin and H2O absorption. Treatments are targeted at the chromophore, reducing patient side effects.

Weighing just 13kg, PRO Yellow is a compact and portable tabletop vascular laser. Its advanced German “solid state” semiconductor diode technology ensures fewer moving parts, making it among the most reliable of today’s laser technologies, with no ongoing consumables cost.

VIEW: PRO Yellow flyer in your browser


Laser High power diode laser
Laserclass 4
Wavelength: 800 Ð 950 nm
Pulse duration: Up to 400 ms
Fluence: Max. 44 J/cm2 @ Spot 14?10 mm (STD)
Max. 90 J/cm2 @ Spot 8?6 mm (HP)
Max. 210 J/cm2 @ Spot 4?3 mm (VAS)
Delivery: Fiber bundle array, sapphire tip
Frequency: Up to 12 Hz
Dimensions: 36.5 x 60 x 46 cm (W x H x D)
Power supply: 100/120/220/230/240 VAC switchable, 50/60 Hz
Weight: Approx. 35 Kg


asclepion laser technologies germany

Country of Origin: Germany
Click the logo above to visit

Better Patient
Broaden Your
Improved Efficacy
Better selective targeting of the chromophore reduces patient side effects

Optional scanning handpiece comes with an integrated skin cooling tool

Flat top beam profile ensures no hot spots
Addresses a broad range of facial vascular concerns, and smaller leg veins

Can be used on a broad range of skin types

Portable and lightweight (just 13 kg), PRO Yellow can be used to treat in a range of settings
The optimal wavelength for the treatment of vascular concerns

Solid state technology means better reliability, more uptime and reduced service costs

No costly consumables

High gloss, easy clean surfaces and ergonomic design reduce both machine and staff downtime


Before & After

Clinical Research Papers